Form 4: Aehr Test Systems VP Reports Future Tax Withholding

Aehr Test Systems VP Alistair N Sporck reported a disposition of 152 common shares for tax withholding purposes related to restricted stock unit vesting, effective January 27, 2026.

Summary

• Alistair N Sporck, VP Contactor Business Unit at Aehr Test Systems, reported a change in beneficial ownership.
• The transaction, made pursuant to a Rule 10b5-1 plan, involves the disposition of 152 shares of common stock on January 27, 2026, at a price of $27.75 per share.
• This disposition is solely for satisfying tax withholding obligations upon the vesting of restricted stock units and does not represent a discretionary sale by the reporting person.
• Following this transaction, Sporck will directly own 28,153 shares (including unvested RSUs) and indirectly own 5,214 shares via a Trust.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding purposes upon RSU vesting, which is a neutral event for the company's operational performance or financial health.

Positives

• Vesting of restricted stock units indicates employee retention and compensation, aligning executive interests with shareholder value.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders may note the ongoing level of insider ownership and the routine nature of executive compensation through restricted stock units.

Key Dates

Recommendation

This Form 4 reports a routine tax withholding transaction related to the vesting of restricted stock units for an executive, executed under a Rule 10b5-1 plan. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is a common occurrence for executive compensation and is not considered price-sensitive.

Keywords

AEHR, insider transaction, Form 4, stock ownership, restricted stock units, tax withholding, 10b5-1 plan